Cadrenal Therapeutics (CVKD) Stock Price & Financial Analysis
Cadrenal Therapeutics Stock Price Chart
Price Chart
Loading chart...
Financial Metrics & Key Statistics
Fundamental metrics, valuation ratios, and profitability indicators
Frequently Asked Questions About Cadrenal Therapeutics
What is the current stock price for CVKD?
As of the latest trading session, CVKD stock trades at $5.05. The 52-week range is $4.21–$16.25, with a day range of $5.04–$5.60.
What is the P/E ratio for CVKD?
The P/E ratio (Price-to-Earnings) for CVKD is shown in the Key Statistics section. This valuation metric helps compare Cadrenal Therapeutics, Inc. to industry peers.
Does CVKD pay dividends?
Cadrenal Therapeutics does not currently pay a regular dividend. The company reinvests earnings into growth and operations. Check the Dividends tab for historical dividend information.
What do analysts recommend for CVKD?
Based on 1 analyst, the consensus for CVKD is Buy. The average 12-month price target is $NaN, representing a NaN% downside from the current price.
What is the market cap of CVKD?
Cadrenal Therapeutics's market capitalization is $10.1M, classifying it as a micro-cap company. Cadrenal Therapeutics operates in the Healthcare sector within the Biotechnology industry.